Company Filing History:
1 out of 13 
1 out of 15 Years Active: 2023-2025
Title: The Innovations of Xinpo Jiang
Introduction
Xinpo Jiang is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, his work focuses on enhancing immune responses for therapeutic applications.
Latest Patents
One of Jiang's latest patents is titled "Humanized anti-human OX40 monoclonal antibody, preparation method therefor and use thereof." This invention relates to a humanized monoclonal antibody that exhibits high affinity and specificity for OX40. It has the potential to stimulate T cells to secrete cytokines, thereby activating the OX40 signaling pathway for tumor immunotherapy. Another significant patent involves "Antibodies and variants thereof against TIGIT." This application provides a monoclonal antibody or an antigen-binding fragment that specifically recognizes TIGIT, along with methods for its use in pharmaceutical compositions.
Career Highlights
Throughout his career, Xinpo Jiang has worked with prominent companies in the biotechnology sector, including Nanjing Genscript Biotech Co., Ltd. and Nanjing Legend Biotech Co., Ltd. His experience in these organizations has contributed to his expertise in antibody development and immunotherapy.
Collaborations
Jiang has collaborated with notable colleagues such as Liusong Yin and Tielin Zhou. Their combined efforts in research and development have further advanced the field of monoclonal antibodies.
Conclusion
Xinpo Jiang's innovative work in the development of monoclonal antibodies showcases his commitment to advancing therapeutic solutions in immunotherapy. His contributions are paving the way for future breakthroughs in the field.